Summit Rock Advisors’s Akero Therapeutics AKRO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q1
Sell
-14,891
Closed -$384K 8
2020
Q4
$384K Buy
+14,891
New +$384K 0.13% 9